Siemens Healthineers AG
XETRA:SHL
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
47.93
57.7
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one SHL stock under the Base Case scenario is 74.29 EUR. Compared to the current market price of 50.82 EUR, Siemens Healthineers AG is Undervalued by 32%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Siemens Healthineers AG
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for SHL cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Siemens Healthineers AG stands at the forefront of medical technology, championing innovation in healthcare that dramatically enhances patient outcomes around the globe. Established as a subsidiary of the industrial giant Siemens AG, the company has carved out its own identity as a leader in diagnostic imaging, laboratory diagnostics, and digital health services. With a rich history spanning over a century, Siemens Healthineers has continuously evolved, investing heavily in research and development to produce cutting-edge technologies such as advanced imaging equipment like MRI and CT scanners. This relentless pursuit of excellence equips healthcare providers with the tools necessary to deli...
Siemens Healthineers AG stands at the forefront of medical technology, championing innovation in healthcare that dramatically enhances patient outcomes around the globe. Established as a subsidiary of the industrial giant Siemens AG, the company has carved out its own identity as a leader in diagnostic imaging, laboratory diagnostics, and digital health services. With a rich history spanning over a century, Siemens Healthineers has continuously evolved, investing heavily in research and development to produce cutting-edge technologies such as advanced imaging equipment like MRI and CT scanners. This relentless pursuit of excellence equips healthcare providers with the tools necessary to deliver accurate diagnoses and efficient patient care, positioning the company as a crucial player in an ever-growing healthcare market.
For investors, Siemens Healthineers presents an enticing opportunity, driven by the increasing global demand for medical advancements and the aging population seeking better healthcare solutions. By capitalizing on trends like digitalization and personalized medicine, the company is poised for sustainable growth, offering a robust portfolio of products and services that cater to a diverse range of medical needs. With a strong commitment to expanding its market presence through strategic partnerships and acquisitions, Siemens Healthineers is not just a provider of medical technology; it’s a pivotal force in reshaping the future landscape of healthcare, making it an attractive investment for those looking to support innovation while reaping financial rewards.
Siemens Healthineers AG is a prominent player in the global healthcare market, offering a diverse range of medical technology solutions and services. The core business segments of Siemens Healthineers can generally be described as follows:
-
Imaging: This segment includes imaging equipment and solutions, such as magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, and molecular imaging technologies. Siemens Healthineers focuses on advancing imaging techniques to improve diagnostic accuracy and patient outcomes.
-
Laboratory Diagnostics: Under this segment, Siemens Healthineers provides a wide array of laboratory diagnostic products, including immunoassay and clinical chemistry systems. This segment aims to support clinical decision-making through accurate laboratory testing and results.
-
Advanced Therapies: This segment encompasses technologies used in minimally invasive surgeries, interventional imaging, and cardiac solutions. Siemens Healthineers develops systems and tools to enhance precision and safety during surgical procedures.
-
Digital Health: Siemens Healthineers is also a key player in the digital health space, offering software solutions that improve workflow in healthcare facilities, data analytics, artificial intelligence applications, and cloud-based services. This segment focuses on enhancing efficiency and effectiveness in patient care delivery.
-
Services: This includes a wide range of services such as consulting, remote diagnostics, maintenance, and training. The services segment aims to maximize the performance of medical technology and ensure that healthcare providers can deliver high-quality patient care.
Overall, Siemens Healthineers focuses on innovation, technology integration, and value-driven solutions to enhance healthcare delivery and improve outcomes for patients and healthcare providers alike.
Siemens Healthineers AG, a prominent player in the healthcare technology sector, possesses several unique competitive advantages that help differentiate it from its rivals:
-
Strong Brand Reputation: Siemens Healthineers has a long-standing reputation and trust in the medical technology industry. Its affiliation with Siemens, a well-established global brand, enhances credibility and customer loyalty.
-
Comprehensive Portfolio: The company offers a wide range of products and services, including advanced imaging systems, laboratory diagnostics, and digital health solutions. This breadth allows them to cater to diverse customer needs and maintain a competitive edge.
-
Innovation and R&D: Siemens Healthineers invests heavily in research and development, driving innovation in areas such as artificial intelligence, precision medicine, and advanced imaging technologies. Their focus on R&D enables them to stay ahead of technological trends and competitors.
-
Integrated Solutions: The company emphasizes providing integrated solutions that combine hardware, software, and services. This holistic approach helps healthcare providers improve operational efficiency and patient outcomes, which is appealing in competitive environments.
-
Global Presence and Scale: With a strong international footprint, Siemens Healthineers can leverage economies of scale, optimize supply chains, and provide support across different markets, making it easier to serve large healthcare systems and institutions.
-
Partnerships and Collaborations: Strategic partnerships with academic institutions, research organizations, and technology firms enhance Siemens Healthineers' capabilities, allowing for the co-development of advanced healthcare solutions and accelerating time to market.
-
Focus on Digitalization: The company is at the forefront of digital healthcare transformation, integrating data analytics, cloud solutions, and artificial intelligence into their offerings. This focus on digital solutions positions them favorably in a market increasingly driven by data.
-
Strong Financial Stability: Siemens Healthineers has robust financial backing from the Siemens AG group, which provides stability for long-term investments and strategic initiatives, allowing the company to weather market fluctuations effectively.
-
Commitment to Sustainability: Siemens Healthineers prioritizes sustainability in its operations and product development. This commitment positions them favorably with environmentally-conscious customers and aligns with global trends towards sustainable healthcare practices.
-
Customer-Centric Approach: They prioritize customer relationships and tailor solutions to meet specific needs in various healthcare settings. This customer-centric model enhances satisfaction and fosters long-term partnerships.
By leveraging these competitive advantages, Siemens Healthineers can effectively navigate the dynamic healthcare landscape and continue to lead in the medical technology sector.
Siemens Healthineers AG, a leading medical technology company, faces several risks and challenges in the near future, including:
-
Regulatory Scrutiny: The healthcare industry is heavily regulated, and any changes in regulations can impact product approval processes, compliance costs, and operational procedures. Stricter regulations globally may pose challenges.
-
Technological Advancements: Rapid technological changes, especially in areas like AI and imaging technologies, require constant innovation and adaptation. Staying ahead of competitors in research and development is crucial.
-
Competitive Pressure: The healthcare technology market is highly competitive, with established players and new entrants constantly emerging. Maintaining market share and competitive advantage is vital.
-
Supply Chain Disruptions: Global events, such as pandemics, geopolitical tensions, or natural disasters, can disrupt supply chains, leading to delays in production and distribution, which can affect revenue.
-
Economic Conditions: Economic downturns or changes in healthcare spending, especially in public healthcare systems, can lead to reduced budgets for medical equipment and technology.
-
Cybersecurity Threats: As more medical devices become connected, the risk of cyberattacks increases. Protecting sensitive patient and operational data is essential for maintaining trust and compliance.
-
Talent Acquisition and Retention: The demand for skilled professionals in the healthcare technology sector is high. Attracting and retaining top talent can be challenging and may impact innovation and service quality.
-
Global Health Crises: Ongoing or future global health challenges, such as pandemics, can strain resources and shift focus away from other business areas, affecting overall performance.
-
Integration of Acquisitions: Siemens Healthineers has a history of growth through acquisitions. Effectively integrating acquired companies into the existing structure can be difficult and may disrupt operations.
-
Market Access and Pricing Pressure: Economic pressures can lead to pricing challenges, as healthcare providers seek to reduce costs. Gaining market access in price-sensitive regions may require strategic adjustments.
-
Sustainability and Environmental Regulations: Increasing focus on sustainability may require investments in environmentally friendly practices and compliance with evolving regulations.
Addressing these risks and challenges will require strategic planning, innovation, and effective risk management strategies. Companies in the healthcare sector must remain agile and adaptive to navigate the complex landscape.
Revenue & Expenses Breakdown
Siemens Healthineers AG
Balance Sheet Decomposition
Siemens Healthineers AG
Current Assets | 14.2B |
Cash & Short-Term Investments | 2.3B |
Receivables | 6.5B |
Other Current Assets | 5.4B |
Non-Current Assets | 32.4B |
Long-Term Investments | 1.6B |
PP&E | 4.4B |
Intangibles | 25.4B |
Other Non-Current Assets | 1.1B |
Current Liabilities | 11.2B |
Accounts Payable | 2B |
Other Current Liabilities | 9.2B |
Non-Current Liabilities | 17.2B |
Long-Term Debt | 14.4B |
Other Non-Current Liabilities | 2.8B |
Earnings Waterfall
Siemens Healthineers AG
Revenue
|
22.1B
EUR
|
Cost of Revenue
|
-13.7B
EUR
|
Gross Profit
|
8.4B
EUR
|
Operating Expenses
|
-5.6B
EUR
|
Operating Income
|
2.7B
EUR
|
Other Expenses
|
-859m
EUR
|
Net Income
|
1.9B
EUR
|
Free Cash Flow Analysis
Siemens Healthineers AG
EUR | |
Free Cash Flow | EUR |
In Q4, Siemens Healthineers achieved impressive revenue growth of 7% year-over-year, with a notable 16% increase in adjusted EPS. Despite challenges in China, margins expanded nearly 100 basis points, driven primarily by Imaging and Advanced Therapies. Free cash flow more than doubled, signaling operational efficiency. Looking ahead, the company anticipates 5-6% revenue growth and adjusted EPS of EUR 2.35 to EUR 2.50 for fiscal 2025, while also addressing a soft Q1 expectation. Key innovations in imaging technologies suggest potential future gains despite ongoing market challenges.
What is Earnings Call?
SHL Profitability Score
Profitability Due Diligence
Siemens Healthineers AG's profitability score is 53/100. The higher the profitability score, the more profitable the company is.
Score
Siemens Healthineers AG's profitability score is 53/100. The higher the profitability score, the more profitable the company is.
SHL Solvency Score
Solvency Due Diligence
Siemens Healthineers AG's solvency score is 47/100. The higher the solvency score, the more solvent the company is.
Score
Siemens Healthineers AG's solvency score is 47/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SHL Price Targets Summary
Siemens Healthineers AG
According to Wall Street analysts, the average 1-year price target for SHL is 60.05 EUR with a low forecast of 50.5 EUR and a high forecast of 69.3 EUR.
Dividends
Current shareholder yield for SHL is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
SHL Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Siemens Healthineers AG operates as a holding company. The company is headquartered in Erlangen, Bayern and currently employs 66,800 full-time employees. The company went IPO on 2018-03-16. The firm offers a wide range of products and services in the fields of diagnostic and therapeutic imaging, laboratory and point of care diagnostics, and molecular medicine. The company provides medical technology and software solutions, as well as clinical consulting services. Additionally, the Company develops its digital health and enterprise services trough expanding precision medicine, transforming care delivery, improving patient experience, and digitalizing healthcare. The firm is active worldwide.
Contact
IPO
Employees
Officers
The intrinsic value of one SHL stock under the Base Case scenario is 74.29 EUR.
Compared to the current market price of 50.82 EUR, Siemens Healthineers AG is Undervalued by 32%.